302 related articles for article (PubMed ID: 32044470)
1. Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity.
Perez DR; Sklar LA; Chigaev A; Matlawska-Wasowska K
Semin Cancer Biol; 2021 Jan; 68():199-208. PubMed ID: 32044470
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.
Perez DR; Smagley Y; Garcia M; Carter MB; Evangelisti A; Matlawska-Wasowska K; Winter SS; Sklar LA; Chigaev A
Oncotarget; 2016 Jun; 7(23):33960-82. PubMed ID: 27129155
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters.
Cheepala S; Hulot JS; Morgan JA; Sassi Y; Zhang W; Naren AP; Schuetz JD
Annu Rev Pharmacol Toxicol; 2013; 53():231-53. PubMed ID: 23072381
[TBL] [Abstract][Full Text] [Related]
4. Cellular efflux of cAMP and cGMP - a question about selectivity.
Sager G; Ravna AW
Mini Rev Med Chem; 2009 Jul; 9(8):1009-13. PubMed ID: 19601896
[TBL] [Abstract][Full Text] [Related]
5. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine.
Guo Y; Kotova E; Chen ZS; Lee K; Hopper-Borge E; Belinsky MG; Kruh GD
J Biol Chem; 2003 Aug; 278(32):29509-14. PubMed ID: 12764137
[TBL] [Abstract][Full Text] [Related]
6. A High-Throughput Flow Cytometry Assay for Identification of Inhibitors of 3',5'-Cyclic Adenosine Monophosphate Efflux.
Perez D; Simons PC; Smagley Y; Sklar LA; Chigaev A
Methods Mol Biol; 2016; 1439():227-44. PubMed ID: 27316999
[TBL] [Abstract][Full Text] [Related]
7. Erlotinib antagonizes ABC transporters in acute myeloid leukemia.
Lainey E; Sébert M; Thépot S; Scoazec M; Bouteloup C; Leroy C; De Botton S; Galluzzi L; Fenaux P; Kroemer G
Cell Cycle; 2012 Nov; 11(21):4079-92. PubMed ID: 23095522
[TBL] [Abstract][Full Text] [Related]
8. Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
Aronsen L; Orvoll E; Lysaa R; Ravna AW; Sager G
Eur J Pharmacol; 2014 Dec; 745():249-53. PubMed ID: 25445042
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension: novel pathways and emerging therapies inhibitors of cGMP and cAMP metabolism.
Sassi Y; Hulot JS
Handb Exp Pharmacol; 2013; 218():513-29. PubMed ID: 24092353
[TBL] [Abstract][Full Text] [Related]
10. D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.
Xie Q; Zhao SP; Li F
Tohoku J Exp Med; 2010 Mar; 220(3):223-8. PubMed ID: 20208418
[TBL] [Abstract][Full Text] [Related]
11. Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.
Herfindal L; Krakstad C; Myhren L; Hagland H; Kopperud R; Teigen K; Schwede F; Kleppe R; Døskeland SO
PLoS One; 2014; 9(4):e94926. PubMed ID: 24740327
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a cyclic adenosine monophosphate-dependent signal in the diet-induced canalicular trafficking of adenosine triphosphate-binding cassette transporter g5/g8.
Yamazaki Y; Yasui K; Hashizume T; Suto A; Mori A; Murata Y; Yamaguchi M; Ikari A; Sugatani J
Hepatology; 2015 Oct; 62(4):1215-26. PubMed ID: 25999152
[TBL] [Abstract][Full Text] [Related]
13. Efflux of cyclic adenosine monophosphate from cells: mechanisms and physiological implications.
Orlov SN; Maksimova NV
Biochemistry (Mosc); 1999 Feb; 64(2):127-35. PubMed ID: 10187903
[TBL] [Abstract][Full Text] [Related]
14. Cell death sensitization of leukemia cells by opioid receptor activation.
Friesen C; Roscher M; Hormann I; Fichtner I; Alt A; Hilger RA; Debatin KM; Miltner E
Oncotarget; 2013 May; 4(5):677-90. PubMed ID: 23633472
[TBL] [Abstract][Full Text] [Related]
15. A new role for a classical gene: white transports cyclic GMP.
Evans JM; Day JP; Cabrero P; Dow JA; Davies SA
J Exp Biol; 2008 Mar; 211(Pt 6):890-9. PubMed ID: 18310115
[TBL] [Abstract][Full Text] [Related]
16. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
DeRubertis FR; Craven PA
Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux.
Lin G; Bornfeldt KE
Biochem Biophys Res Commun; 2002 Jan; 290(2):663-9. PubMed ID: 11785950
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.
Chiavegatti T; Costa VL; Araújo MS; Godinho RO
Br J Pharmacol; 2008 Mar; 153(6):1331-40. PubMed ID: 18157164
[TBL] [Abstract][Full Text] [Related]
19. Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha.
Yin Y; Allen PD; Jia L; MacEy MG; Kelsey SM; Newland AC
Br J Haematol; 2000 Mar; 108(3):565-73. PubMed ID: 10759715
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells.
Wielinga PR; van der Heijden I; Reid G; Beijnen JH; Wijnholds J; Borst P
J Biol Chem; 2003 May; 278(20):17664-71. PubMed ID: 12637526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
